Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer
Shumin Li, Yue Ming, Haiyan Xu, et al.
Cancer Letters (2023) Vol. 564, pp. 216206-216206
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles
Yixiang Hu, Ya Liu, Lijuan Zong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 27
Pancreatic Cancer Cell-derived Migrasomes Promote Cancer Progression by Fostering an Immunosuppressive Tumor Microenvironment
Ronghua Zhang, Junya Peng, Yalu Zhang, et al.
Cancer Letters (2024) Vol. 605, pp. 217289-217289
Closed Access | Times Cited: 10
Photothermal therapy combined with a STING agonist induces pyroptosis, and gasdermin D could be a new biomarker for guiding the treatment of pancreatic cancer
Yanyan Hu, Erpeng Qi, C. Chris Yun, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Pyroptosis: shedding light on the mechanisms and links with cancers
Hong‐mei You, Ling Wang, Hongwu Meng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: a single-center retrospective analysis
Rong Hua, Hong-Fei Yao, Zi-Yu Song, et al.
Cancer Letters (2024) Vol. 603, pp. 217213-217213
Closed Access | Times Cited: 6
Macroautophagy/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis
Leng Han, Lingjun Meng, Jiao Liu, et al.
Cancer Letters (2024) Vol. 604, pp. 217258-217258
Open Access | Times Cited: 6
SIRT7 knockdown promotes gemcitabine sensitivity of pancreatic cancer cell via upregulation of GLUT3 expression
Keyu Chen, Tiane Li, Honglin Diao, et al.
Cancer Letters (2024) Vol. 598, pp. 217109-217109
Closed Access | Times Cited: 5
Engineering materials for pyroptosis induction in cancer treatment
Jiayi Liu, Taili Chen, XianLing Liu, et al.
Bioactive Materials (2023) Vol. 33, pp. 30-45
Open Access | Times Cited: 12
Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and Translational Perspectives
Pengyu Li, Hanyu Zhang, Menghua Dai
Cancer Letters (2024) Vol. 604, pp. 217274-217274
Closed Access | Times Cited: 4
LXR agonists induces GSDME-mediated pyroptosis in tumors through alters the integrity of the MOM to activates Caspase-4/APAF-1 pyroptosome
Xiaoli Ju, Heng Zhang, Jin Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 142568-142568
Closed Access
Therapeutic connections between pyroptosis and paclitaxel in anti-tumor effects: an updated review
Shuxin Song, Jingbo Wang, Xiaohu Ouyang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy
Mojtaba Tarin, Amir Sh. Saljooghi
Biochemical Pharmacology (2025), pp. 116961-116961
Closed Access
Boarding pyroptosis onto nanotechnology for cancer therapy
Weiyue Ban, Zhichao Chen, Tao Zhang, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 653-676
Closed Access | Times Cited: 3
YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer
Borui Li, Faliang Xing, Jingyi Wang, et al.
Cancer Letters (2024) Vol. 602, pp. 217197-217197
Open Access | Times Cited: 3
Inhibition of TGF-β signaling in bone marrow endothelial cells promotes hematopoietic recovery in acute myeloid leukemia patients
Zhenkun Wang, Zhiwei Zhang, Zhong‐Shi Lyu, et al.
Cancer Letters (2024) Vol. 605, pp. 217290-217290
Closed Access | Times Cited: 3
Ribosome Biogenesis, Altered Metabolism and Ribotoxic Stress Response in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
Sanjib Chaudhary, Jawed A. Siddiqui, Ramesh Pothuraju, et al.
Cancer Letters (2025), pp. 217484-217484
Closed Access
Cell death in acute lung injury: caspase-regulated apoptosis, pyroptosis, necroptosis, and PANoptosis
Jun Xiao, Lichuan Wang, Bohan Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
NRXN3 regulates pyroptosis in intrahepatic cholangiocarcinoma via mediating the phospho-dependent ubiquitination and degradation of caspase-3
Tao Zhou, Yaodong Zhang, Tianlin Wang, et al.
Journal of Advanced Research (2025)
Open Access
An analysis of gasdermin family of genes in UCEC with respect to malignancy status, mutation percentages and histologic diagnosis
Çağlar Berkel
Genome Instability & Disease (2024) Vol. 5, Iss. 3, pp. 105-115
Open Access | Times Cited: 3
Cisplatin-induced pyroptosis: a double-edged sword in cancer treatment
Wenyang Lei, Wenting Yu, Yu Zhong, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 5, pp. 711-720
Closed Access | Times Cited: 2
Tiny pH-Resolved DNA Nanospheres for Cellular Pyroptosis or Apoptosis Regulation
Yu Chen, Xiaoyi Liu, Yu Guo, et al.
Nano Letters (2024)
Closed Access | Times Cited: 2
IMB5036 overcomes resistance to multiple chemotherapeutic drugs in human cancer cells through pyroptosis by targeting the KH-type splicing regulatory protein
Qi Zhao, Xing Lv, Yanqun Dong, et al.
Life Sciences (2023) Vol. 328, pp. 121941-121941
Closed Access | Times Cited: 6
Signalling in pancreatic cancer: from pathways to therapy
Kexun Zhou, Yingping Liu, Shiman Yuan, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 10, pp. 1013-1026
Closed Access | Times Cited: 5
Research Progress on Pyroptosis in Hematological Malignancies
Tianxin Lyu, Qingsong Yin
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 10, pp. 1439-1450
Open Access | Times Cited: 4
Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?
Erfaneh Barar, Jiaqi Shi
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2792-2792
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top